SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009920
Filing Date
2023-05-15
Accepted
2023-05-15 16:51:10
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20230331x10q.htm   iXBRL 10-Q 1212203
2 EX-31.1 rsls-20230331xex31d1.htm EX-31.1 11728
3 EX-31.2 rsls-20230331xex31d2.htm EX-31.2 11976
4 EX-32.1 rsls-20230331xex32d1.htm EX-32.1 9397
5 EX-32.2 rsls-20230331xex32d2.htm EX-32.2 9210
  Complete submission text file 0001558370-23-009920.txt   5420200

Data Files

Seq Description Document Type Size
6 EX-101.SCH rsls-20230331.xsd EX-101.SCH 39455
7 EX-101.CAL rsls-20230331_cal.xml EX-101.CAL 48501
8 EX-101.DEF rsls-20230331_def.xml EX-101.DEF 200217
9 EX-101.LAB rsls-20230331_lab.xml EX-101.LAB 345525
10 EX-101.PRE rsls-20230331_pre.xml EX-101.PRE 296445
55 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20230331x10q_htm.xml XML 841333
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 23923720
SIC: 3841 Surgical & Medical Instruments & Apparatus